JPMorgan analysts see tough road ahead for Humana if Aetna deal blocked

JPMorgan analysts slashed the target price of Humana from $196 to $150 after reports the DOJ may block the acquisition by Aetna.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.